SLN ▲ +5.0% - Silence Therapeutics plc
$SLN Merck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset
19-OCT-2026 08:04 AM ET
Share this post
More filings for $SLN
View full $SLN filing history →💬 Comments
Loading comments…
Leave a comment
